Francisco Martín-Molina

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research Spain

Dr Martin Molina is the Principal investigator of the Gene and Cell Therapy group at the department of human variability in the Centre for Genomics and Oncological Research (GENYO). He is PhD in Biology (extraordinary Price) by the CSIC-University of Granada in 1995. He worked in London from 1997 to 2003, first at the ICR Chester Beaty and then at the Windeyer Institute of Medical Sciences (UCL) where he worked on retroviral vectors targeting to tumor cells for cancer immunotherapy. From 2003 to 2009 Dr Martin Molina consolidates his own research group thanks to a Miguel Servet and a Ramon y Cajal contracts. From 2009 he is Principal Investigator from the Fundación Progreso y Sadud, first at the Andalusian Stem Cell Bank (BACM) and then at GENYO. His group main interest is the development of safer and more efficient gene delivery tools for the treatment of immune-related diseases: Immunodeficiencies (Wiskott-Aldrich Syndrome) and autoimmune diseases (Multiple sclerosis). He has published over 35 international publications in high impact journals. His publications have been cited over 710 times and have an accumulate impact factor of 202.

Francisco Martín-Molina

1books edited

3chapters authored

Latest work with IntechOpen by Francisco Martín-Molina

The Gene Therapy field is living exciting times after more than 20 years of poor results. Scientist and clinicians working in the gene therapy field have encountered many problems in the past that are now starting to be solved. The development of safer and more efficient gene transfer vectors and the advances on the cell therapy field have open new opportunities to tackle different diseases. The aim of this book is to bring together information about the different gene therapy tools, the clinical successes of gene therapy and the future applications.

Go to the book